Medical Decisions, Estrogen and AgingSpringer Science & Business Media, 20.12.2007 - 178 Seiten If you are a woman between the ages of 45 and 75 and are trying to decide whether to try, or stick with, hormone therapy (HT), or if you are a physician with patients fitting this description, this book is for you – unless you are looking for a simple answer. If you are looking for a simple answer, you can go to the web site of one of the companies that manufactures hormones or makes money by administering hormone therapy (e. g. , AntiAgingGroup. com), or you can go to the we bsite of an organization that advocates ‘natural’ aging (e. g. , the Inter National Organization to Reclaim Menopause; Inorm. org). Any impartial advisor, however, is going to admit that the answer isn’t at all clear-cut. Jay Schulkin, I believe the reader will find, is such an impartial advisor, and he is going to take you several steps beyond simply acknowledging the ambiguity; he’s going to educate you about the biology, history, sociology, business, and ethics of hormone replacement therapy. As a prominent scientist doing research on hormones, a medical researcher, an expert on decision making, he is the ideal guide to the intricacies of the topic. You might think that all of this sounds superfluous for making an informed decision: “Just the facts, please. |
Inhalt
ter | 4 |
Autonomic Regulation Heart and Strokes 49 | 50 |
Cancers and Bone | 69 |
Conclusion | 85 |
Conclusion | 102 |
6 | 121 |
Hormones and Resonable Expectations of Aging | 125 |
154 | |
Andere Ausgaben - Alle anzeigen
Häufige Begriffe und Wortgruppen
analysis appear associated benefits bias biases bone brain breast cancer changes choice clinical cognitive compounds considered context continue culture decision decision-making decline decrease depression diverse doctors drug early effects enhance estrogen et al Ethics evidence evidence-based example expectations experience fact factors findings forms fractures function glucose guidelines heart disease hormone replacement therapy hormone therapy human important increased increased risk Initiative issues knowledge less levels linked look loss major medicine memory menopause mg/day natural older osteoporosis particularly patients performance perhaps period pharmaceutical physicians placebo positive postmenopausal women practice prescribing Press prevention progestin protection randomized reasoning reduced regard reported response risk Schulkin scientific sense showed social subjects suggested symptoms tests treatment trials understand values vulnerability WHI studies
Beliebte Passagen
Seite 164 - Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
Seite 153 - JG ( 1994) Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.
Seite 147 - B: A randomized, open, parallelgroup study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999; 180: 1072-1079.